Literature DB >> 8896411

High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles.

Y Miyazaki1, S Nomura, T Miyake, H Kagawa, C Kitada, H Taniguchi, Y Komiyama, Y Fujimura, Y Ikeda, S Fukuhara.   

Abstract

Previous studies have demonstrated that a high level of shear stress can produce platelet aggregation without the addition of any agonist. We investigated whether high shear stress could cause both platelet aggregation and shedding of microparticles from the platelet plasma membrane. A coneplate viscometer was used to apply shear stress and microparticle formation was measured by flow cytometry. It was found that microparticle formation increased as the duration of shear stress increased. Both microparticles and the remnant platelets showed the exposure of procoagulant activity on their surfaces. Investigation of the mechanisms involved in shear-dependent microparticle generation showed that binding of von Willebrand factor (vWF) to platelet glycoprotein lb, influx of extracellular calcium, and activation of platelet calpain were required to generate microparticles under high shear stress conditions. Activation of protein kinase C (PKC) promoted shear-dependent microparticle formation. Epinephrine did not influence microparticle formation, although it enhanced platelet aggregation by high shear stress. These findings suggest the possibility that local generation of microparticles in atherosclerotic arteries, the site that pathologically high shear stress could occur, may contribute to arterial thrombosis by providing and expanding a catalytic surface for the coagulation cascade.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896411

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  76 in total

Review 1.  Function and clinical significance of platelet-derived microparticles.

Authors:  S Nomura
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

2.  Oxidized low-density lipoprotein-dependent platelet-derived microvesicles trigger procoagulant effects and amplify oxidative stress.

Authors:  Hua Wang; Zhi-Hao Wang; Jing Kong; Meng-Yun Yang; Gui-Hua Jiang; Xu-Ping Wang; Ming Zhong; Yun Zhang; Jing-Ti Deng; Wei Zhang
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

Review 3.  Clinical relevance of microparticles from platelets and megakaryocytes.

Authors:  Joseph E Italiano; Albert T A Mairuhu; Robert Flaumenhaft
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

4.  Numerical investigation of the effects of channel geometry on platelet activation and blood damage.

Authors:  Jingshu Wu; B Min Yun; Anna M Fallon; Stephen R Hanson; Cyrus K Aidun; Ajit P Yoganathan
Journal:  Ann Biomed Eng       Date:  2010-10-26       Impact factor: 3.934

Review 5.  Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes.

Authors:  Majed A Refaai; Richard P Phipps; Sherry L Spinelli; Neil Blumberg
Journal:  Thromb Res       Date:  2010-11-19       Impact factor: 3.944

6.  Migration distance-based platelet function analysis in a microfluidic system.

Authors:  Suk-Heung Song; Chae-Seung Lim; Sehyun Shin
Journal:  Biomicrofluidics       Date:  2013-11-04       Impact factor: 2.800

Review 7.  Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions?

Authors:  Anastasios Kriebardis; Marianna Antonelou; Konstantinos Stamoulis; Issidora Papassideri
Journal:  Blood Transfus       Date:  2012-05       Impact factor: 3.443

Review 8.  Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery.

Authors:  Michael L Merchant; Ilse M Rood; Jeroen K J Deegens; Jon B Klein
Journal:  Nat Rev Nephrol       Date:  2017-10-30       Impact factor: 28.314

9.  Effects of upstream shear forces on priming of platelets for downstream adhesion and activation.

Authors:  Shekh M Rahman; Colin D Eichinger; Vladimir Hlady
Journal:  Acta Biomater       Date:  2018-04-11       Impact factor: 8.947

10.  Losartan and simvastatin inhibit platelet activation in hypertensive patients.

Authors:  Shosaku Nomura; Akira Shouzu; Seitarou Omoto; Mitsushige Nishikawa; Shirou Fukuhara; Toshiji Iwasaka
Journal:  J Thromb Thrombolysis       Date:  2004-12       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.